Chemed Corp. (NYSE:CHE) insider Spencer S. Lee sold 4,500 shares of the firm’s stock in a transaction dated Monday, November 14th. The shares were sold at an average price of $150.22, for a total transaction of $675,990.00. Following the transaction, the insider now directly owns 35,367 shares in the company, valued at approximately $5,312,830.74. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Chemed Corp. (NYSE:CHE) opened at 145.80 on Thursday. The stock’s 50 day moving average is $140.50 and its 200 day moving average is $136.95. The company has a market cap of $2.37 billion, a price-to-earnings ratio of 23.27 and a beta of 1.25. Chemed Corp. has a 52-week low of $124.77 and a 52-week high of $159.76.

Chemed Corp. (NYSE:CHE) last posted its quarterly earnings results on Wednesday, October 26th. The company reported $1.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.82 by $0.09. Chemed Corp. had a return on equity of 23.95% and a net margin of 6.77%. The business had revenue of $392.61 million for the quarter, compared to analyst estimates of $270.44 million. During the same quarter in the prior year, the firm earned $1.78 EPS. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. Equities research analysts forecast that Chemed Corp. will post $7.25 earnings per share for the current year.

Insider Buying and Selling by Quarter for Chemed Corp. (NYSE:CHE)

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 5th. Shareholders of record on Monday, November 14th will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, November 9th. This represents a $1.04 dividend on an annualized basis and a yield of 0.71%. Chemed Corp.’s dividend payout ratio is currently 16.59%.

A number of large investors have recently bought and sold shares of CHE. Gerstein Fisher increased its stake in shares of Chemed Corp. by 0.4% in the third quarter. Gerstein Fisher now owns 7,405 shares of the company’s stock valued at $1,045,000 after buying an additional 28 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its stake in shares of Chemed Corp. by 1.1% in the third quarter. Municipal Employees Retirement System of Michigan now owns 3,670 shares of the company’s stock valued at $518,000 after buying an additional 40 shares in the last quarter. Public Employees Retirement System of Ohio increased its stake in shares of Chemed Corp. by 3.5% in the second quarter. Public Employees Retirement System of Ohio now owns 1,319 shares of the company’s stock valued at $180,000 after buying an additional 45 shares in the last quarter. Smith Salley & Associates increased its stake in shares of Chemed Corp. by 3.4% in the second quarter. Smith Salley & Associates now owns 1,815 shares of the company’s stock valued at $247,000 after buying an additional 60 shares in the last quarter. Finally, Bell State Bank & Trust increased its stake in shares of Chemed Corp. by 3.2% in the third quarter. Bell State Bank & Trust now owns 2,392 shares of the company’s stock valued at $337,000 after buying an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 98.61% of the company’s stock.

CHE has been the topic of several research analyst reports. Zacks Investment Research raised shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $167.00 target price on the stock in a research note on Thursday, July 28th. JMP Securities reissued a “hold” rating on shares of Chemed Corp. in a research note on Sunday, September 4th. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $155.00 target price on shares of Chemed Corp. in a research note on Tuesday, September 27th. RBC Capital Markets reissued a “sector perform” rating and set a $162.00 target price (up previously from $136.00) on shares of Chemed Corp. in a research note on Wednesday, July 27th. Finally, Royal Bank Of Canada raised their target price on shares of Chemed Corp. from $136.00 to $162.00 and gave the company a “sector perform” rating in a research note on Wednesday, July 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $154.50.

Chemed Corp. Company Profile

Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

5 Day Chart for NYSE:CHE

Receive News & Stock Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related stocks with our FREE daily email newsletter.